Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.

Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.

Item
http://www.wikidata.org/entity/Q34724226
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.Review of mifamurtide in the treatment of patients with osteosarcoma.The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin.Toward a drug development path that targets metastatic progression in osteosarcoma.Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis.Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentStrategies and developments of immunotherapies in osteosarcomaThe Current and Future Therapies for Human Osteosarcoma.Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.Mifamurtide for the treatment of nonmetastatic osteosarcomaThe immunotherapy of canine osteosarcoma: a historical and systematic review.Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
P2860

Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.

Item
http://www.wikidata.org/entity/Q34724226
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@ast
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@en
Efficacy of liposomal muramyl tripeptide
@nl
type
label
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@ast
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@en
Efficacy of liposomal muramyl tripeptide
@nl
prefLabel
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@ast
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@en
Efficacy of liposomal muramyl tripeptide
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Efficacy of liposomal muramyl ...... ment of relapsed osteosarcoma.
@en
P2093
P304
P31
P433
P478
P577
P698